The goal is to harness a fraction of the profound health benefits observed in people with medical conditions such as obesity and type 2 diabetes when they take standard doses of GLP-1smaybe with fewer side effects
In PNA mice, treatment with the lower dose of GLP1/E had also superior metabolic efficacy vs
Endocrinologists viewed their ideal patient as an individual with established cardiovascular disease or high cardiovascular risk, including those with diabetic kidney disease, who are already being treated with more than one oral medication (including either SGLT2is or GLP1-RAs) and an HbA1c level exceeding the established target
Choosing the right clinician for weight loss therapy can make all the difference in achieving meaningful, lasting results
Sean Scanlon, the Connecticut comptroller, said that not covering GLP-1s is shortsighted, bad policy. The state health plan, which takes care of teachers and other state employees, has been covering the drugs for weight loss since 2023
Reconstitution Principles Used in Labs Reconstitution is not about speed